Center for Vaccines and Immunology

Leading the way in immunology and vaccine development

Established in 2015, the Center for Vaccines and Immunology (CVI) is made up of a premier team of researchers that are leading the way in basic and translational research in immunology and vaccine development.

CVI Faculty

CVI at a glance

10

Faculty

2

GRA Scholars

22

Industrial Agreements

$ 10.7 M

FY20 grant funding

UGA is the logical home for the CVI thanks to its diverse, world-renowned expertise within the areas of infectious disease, veterinary medicine, ecology and public health. With UGA’s world-class biocontainment research resources coupled with the expertise of scientists from nearby institutions, CVI investigators can focus on translational studies to test and assess the efficacy of vaccines and immunotherapies in development by industry, governmental and academic institutions.

CVI Seminar Series

Seminars are held on Wednesdays at 11 AM unless otherwise noted. Seminars will continue being held via Zoom for the 2021 Spring semester. E-mail nell1234@uga.edu for passcodes.

Date Speaker Institution Topic Meeting ID
Jan 13 2021 Chester Joyner University of Georgia Extrafollicular B cell activation may underpin persistent anemia during chronic Plasmodium infections 954 2459 9982
Jan 20 2021 Alessandro Sette La Jolla Institute for Immunology The study of adaptive responses to SARS CoV2 960 8175 3410
Jan 27 2021 Andreas Wack Crick Institute Lung epithelia under attack: Infection, Interferon, Inflammation 920 1740 6008
Feb 10 2021 Aaron Gingerich/ Jiachen Huang University of Georgia Human monoclonal antibodies targeting the pneumococcal histidine triad protein protect against pneumococcal infection/Defining the neutralizing epitopes on the human metapneumovirus fusion protein 945 7985 2658
Feb 17 2021 Amar Singh University of Georgia Stem cell-derived adipocytes: tools for obesity-associated disease studies 922 9390 3607
Feb 24 2021 Lydie Trautmann Oregon Health and Sciences University HIV remission: Lessons from very early treatment in HIV infection 951 6848 6637
Mar 10 2021 Noah Sather Seattle Children’s Research Institute Non-neutralizing antibodies against malaria: irrelevant bystanders or insidious foes? 947 5532 9651
Mar 31 2021 Bo Liang Emory University TBA 979 8345 5553
Apr 07 2021 Sunny Jang University of Georgia TBA 963 9470 1289
Apr 21 2021 David Forgacs University of Georgia Lessons learned from SPARTA, a large-scale SARS-CoV-2 antibody surveillance program 922 5102 3059
Apr 28 2021 Wayne Cheng/ Whitney Rabacal University of Georgia TBA 937 5774 0679

Latest CVI news and stories

UGA-led COVID study seeks more applicants

January 2021: In September 2020, the College of Veterinary Medicine announced SPARTA (SARS SeroPrevalence and Respiratory Tract Assessment), a study…

Related to the CVI

Changing the face of animal and human health through research

Our researchers are actively looking for solutions to common problems and challenges facing the world today.

University research resources

The University of Georgia's Office of Research is committed to supporting and advancing research here.